OBJECTIVES: To determine whether 12 initial weeks on a Very Low Calorie Diet (VLCD) included in a two-year support program is associated with better long term weight loss maintenance than a dietary and behavioural support program alone. Additionally, to identify characteristics associated with successful treatment or attrition, which can be used in selecting individuals likely to respond to VLCD-programs. DESIGN: Randomised clinical trial. SETTING: Two Swedish out-patient clinics. SUBJECTS: 113 obese men and women aged 37±58 y, body mass index (BMI) b 32.0 kg/m 2 , participating in the Swedish Obese Subjects-(SOS) study. INTERVENTIONS: One group received VLCD for 12 initial weeks plus regular dietary and behavioural support over two years while the other group received two years of the same supportive program only. MAIN OUTCOME MEASURE: Weight loss after two years treatment. RESULTS: Both treatment groups maintained highly signi®cant weight losses at two years but the initial VLCDtreatment appeared to have given no signi®cant long term bene®t compared to the supportive program. Examination of selected demographic, psychosocial and dietary characteristics showed that the VLCD-approach was more effective than the supportive strategy alone in men and possibly in individuals sharing household with only one person. High initial hunger-score was associated with attrition, irrespective of treatment. CONCLUSION: A VLCD-program including long term dietary and behavioural support is a successful treatment for some severely obese subjects, especially men. Further research should be directed towards matching treatments to individuals in order to improve the high recidivism rates generally following weight loss attempts.
Introduction
There is almost no treatment for obesity that results in long term maintenance of weight loss, except surgery, and almost all conventional weight loss programs are followed by weight regain. 1, 2 Very Low Calorie Diets (VLCD) and hypocaloric diets are well established weight loss strategies. 1, 3 VLCDs have been proposed as a means of accelerating the active weight loss process. However, VLCDprograms have been criticised for failure to incorporate basic nutritional principles. 4 Whether VLCDprograms result in greater long term weight loss than hypocaloric diets is not known. Studies with treatment-and follow up-periods of less than two years indicate that VLCD-programs are not superior to strategies based on hypocaloric diets in maintaining weight loss. 3 We are aware of no randomised studies comparing VLCD-programs to programs based on hypocaloric diet and behavioural support for treatment periods of two years or more. It is however a well known clinical observation that a subset of patients do maintain a substantial weight loss when treated with VLCD as well as with programs based on hypocaloric diets. Several authors have pointed out the need to identify individuals most likely to bene®t more from a certain treatment rather than trying to ®nd a treatment that ®ts all obese.
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Our main aim was to conduct a study designed to determine whether 12 initial weeks of VLCD, included in a two-year dietary and behavioural support program, resulted in better maintenance of weight loss after two years of active treatment, than the same supportive treatment alone. We also wanted to identify subgroups that maintained weight loss better on the VLCD-program than on the supportive program.
For instance it may be speculated that demographic factors, dietary preferences or other related psychosocial characteristics might be associated with the ef®-cacy of VLCD-treatment. Finally, we wanted to identify baseline characteristics that could predict attrition.
Methods
The SOS framework Swedish Obese Subjects (SOS) is a nationwide study on obesity, conducted at 480 primary health care centres and 30 departments of surgery in 19 Swedish counties. Obese subjects, aged 37±60 y, are recruited by advertisements in newspapers. The SOS-study consists of two parts: a registry study and an intervention study. The registry study includes analyses of biochemical risk factors, anthropometric measurements and extensive questionnaires. In the intervention study, subjects are matched in pairs: one pair member is treated with bariatric surgery and the other with conventional weight reducing techniques available in primary health care. Details of the SOS-study have been published elsewhere. 8 In A È lvsborg county, the primary health care centres have not participated in the SOS-study and have been replaced by the outpatient clinics at the departments of medicine at NA È L and Skene county hospitals.
Subjects
In A È lvsborg, 361 subjects volunteered for the SOSstudy between November 1991 and December 1993.
After the registry study 113 subjects were excluded or did not want to participate further (see Reference 8 for SOS exclusion criteria). Of the remaining 248 subjects, 122 were treated with bariatric surgery and 126 were eligible for conventional treatment. Of these, 113 subjects (39 men and 74 women, aged 47.1 AE 6.2 y, body mass index (BMI) 40.4 AE 3.8 kg/m 2 ) were randomised either to 12 initial VLCD-weeks included in a dietary and behavioural support program (the VLCD-group) or to the same support program alone (the non VLCD-group).
Thus, 89.7% of the SOS patients eligible for conventional treatment in A È lvsborg county were randomised to the present trial. Baseline data of the study groups are given in Tables 1a and 1b.
Design Figure 1 describes the overall study design and patient visits. The study was approved by the ethics committee of the Faculty of Medicine, University of Go Èteborg and all patients gave informed consent before randomisation.
Randomisation
Subjects were randomised consecutively to either treatment group, using a set of 100 sealed envelopes No signi®cant differences were observed between the treatment groups, neither in total nor when strati®ed by gender. a Percent of total energy intake. No signi®cant differences were observed between the VLCD-and non VLCD-group. When treatment groups were strati®ed by gender there was a signi®cant difference in persons per household among men, chi 2 P`0.001. No other signi®cant differences were observed. a The educational level was separated into low (L), intermediate (I) or high (H) and subjects per level are given in %. b Subjects were separated in three household categories; one-person households (O), two-person households (T) or large households (L). Subjects per category are given in %.
VLCD and behavioural support, two-year data JS:son Torgerson et al per hospital, prepared in random order by a staff member at the SOS-secretariat who did not participate further in the study.
VLCD-treatment
Subjects in the VLCD-group were provided with Modifast 1 , (NOVARTIS Nutrition, Bern, Switzerland) as VLCD and were recommended 1909± 2545 kJ/d (456±608 kcal/d). The higher kJ-level was recommended to men with high energy expenditure. The VLCD-treatment lasted for 12 weeks and thereafter a hypocaloric diet was gradually introduced. A standard blood chemistry pro®le and ECGs were analysed seven times during the VLCD-phase (at randomisation and the six following minor visits).
Dietary treatment
After 12 VLCD-weeks (the VLCD-group) or directly after randomisation (the non VLCD-group), all subjects were advised to consume an individualised hypocaloric diet aiming at a daily energy intake of 5.0±5.9 MJ (1200±1400 kcal) for women or 5.9± 7.5 MJ (1400±1800 kcal) for men with 15±20 percent of the energy intake (E%) from protein, 25±30 E% from fat and 50±55 E% from carbohydrates. At randomisation and every six months (major visits) patients met a dietitian for individual nutritional counselling. Food records were kept for 4 d before each visit and analysed records were discussed with each patient. Cooking groups were arranged (not shown in Figure 1 ).
Supportive behavioural program
At weeks 1, 2, 4, 6, 8, 12, 16 F F F 100 (minor visits), patients met a nurse/dietitian for support and further education on nutrition and life style. Weight was measured at each visit. Patients in the VLCD-group restarted this schedule after 12 weeks, when shifting to the hypocaloric diet, to facilitate refeeding. They were thus offered three more visits during the study period than the non VLCD-patients. At these regular minor visits, as well as at the half-year major visits to the dietitian, behavioural strategies were discussed. Patients were taught`every day' strategies to control their eating behaviour, for example, eating at one speci®c place at home; not watching TV when eating; not shopping when hungry or without a shopping list and eating regular meals at ®xed times. Attempts were also made to identify risk circumstances for overeating and strategies to avoid these situations were discussed. All subjects were encouraged to take part in physical activities and groups for swimming and physical training were offered (not shown in Figure 1 ). Each patient met the physician responsible at all major visits, for physical examination, evaluation of risk factors and counselling.
Measurements
Fourteen baseline variables were examined to ®nd possible predictors of successful treatment or attrition. These variables are listed in Tables 1a and 1b (BMI,  not VLCD and behavioural support, two-year data JS:son Torgerson et al All subjects were classi®ed regarding their baseline smoking habits: non-smokers or current daily smokers. Food intake and alcohol consumption were assessed by means of a validated questionnaire that describes usual dietary intake during the last three months. 9 In addition, all subjects completed a Swedish translation of the Three Factor Eating Questionnaire (TFEQ). 10, 11 The questionnaire measures three different aspects of eating: restrained eating (a conscious restriction of food intake in order to control body weight or promote weight loss), disinhibition (uncontrolled and/or emotional eating) and hunger (subjective feelings of hunger).
Education was used as a measure of socio-economic status. Subjects were divided in three educational levels: Low, including elementary-and comprehensive school; Intermediate, including vocational-or folk high school and High, including high school and university. Data on household size were also analysed and three household categories were created: One-person households, Two-person households and Large households (! three persons).
Statistics
Analyses were performed on the 87 subjects who completed the whole study, as well as on all 113 subjects, on an intention to treat basis with last observation carried forward. Analyses of attritionpredictors were performed on 110 subjects, as three subjects dropped out due to reasons unrelated to the treatment strategies as such and were therefore excluded from further analyses. For statistics, the Minitab statistical package was used.
12 Two-sample t-test, chi-square test and multiple linear regression analyses were used. For variables not normally distributed (weight loss, energy intake and E% alcohol) Fisher's test for paired comparison and Fisher's permutation test were used.
An exploratory analysis of interaction was performed to identify subgroups that maintained weight loss better on VLCD-treatment. An interaction between treatment strategy and a certain baseline variable indicates that the effect of treatment (weight loss) varies according to that variable. Interaction was tested by multiple regression analyses with weight loss at 24 months as the dependent variable, treatment (VLCD 1, non VLCD 2), baseline variable, and the cross-product of treatment and a certain baseline variable as independent variables. An interaction was considered signi®cant if P 0.05 for the cross-product and suggestive when P 0.1.
Results

Patient characteristics
Tables 1a and 1b describe the baseline patient characteristics. There were no signi®cant differences between the treatment groups, neither in total nor when strati®ed by gender, except for the number of persons per household between the two male treatment groups. If only baseline data of the 87 subjects that completed the study were analysed, no signi®cant differences were found (not shown). No serious adverse effects of VLCD were seen and no serious or unexpected laboratory aberrations in the blood chemistry pro®les or ECGs appeared. Figure 2 shows weight changes in the VLCD-and non VLCD-group. After 24 months, weight reduction among completers was 79.2 AE 14.2(s.d.) kg in the VLCD-group and 76.3 AE 9.4 kg in the non VLCDgroup (not statistically signi®cant (ns)). Weight losses analysed on an intention to treat basis were 79.2 AE 13.0 kg and 76.2 AE 8.7 kg, respectively (ns). If expressed as percentage of baseline body weight, weight losses were 77.4 AE 11.3% in the VLCD-group and 75.4 AE 7.9% in the non-VLCD-group (ns). Intention to treat analyses showed 77.6 AE 10.5% and 75.3 AE 7.3% respectively (ns). Within each treatment group, weight losses at 24 months were highly signi®cant, (P`0.001).
Treatment differences
Group speci®c treatment differences
Fourteen baseline variables were tested for possible interaction with treatment strategy (Tables 1a and 1b) . Two signi®cant interactions were found: gender Â treatment, (P 0.031) and household size 6 treatment, (P 0.012). If the regression models were adjusted for baseline weight the P-values were 0.065 and 0.039, respectively. The P-values for the other 12 possible interactions varied between 0.2 and 1.0. This suggests that the treatment strategies had different effects in men vs women and in subjects living in households of different sizes. Figure 3 shows weight losses strati®ed by gender and treatment. At 24 months, completers in the male VLCD-group had lost 715.5 AE 17.2 kg, while the male non VLCD-group had lost 75.3 AE 9.8 kg, (P 0.05). Weight losses among the female subjects that completed the study were, 75.6 AE 11.0 kg and 76.8 AE 9.3 kg, respectively (ns). If analysed on an intention to treat basis, weight losses were 713.0 AE 15.6 kg in the male VLCD-group and 75.8 AE 9.7 kg in the non VLCD-group, (P 0.1). Among women the corresponding weight losses were 76.8 AE 10.6 kg and 76.4 AE 8.4 kg (ns). Figure 4 shows the proportion of subjects in the four gender-treatment constellations by percentage weight loss (`5%, 5±10% or b 10% of baseline weight) at 24 months. Among male completers the distribution of percentage weight loss in the VLCDgroup was signi®cantly different from the non VLCDgroup, (P`0.001). The same results were obtained if data were analysed on an intention to treat basis (not shown). If 10% weight loss was used as partition line for success, 33% of the male VLCD-patients maintained b 10% weight loss compared to 19% among the male non VLCD-patients, (P`0.05), (intention to treat analysis, ns). If, instead, 5% weight loss was the cut-off, 73% of the VLCD-males maintained b 5% weight loss, while only 38% of the subjects in the non VLCD-group achieved the same amount of weight loss, (P`0.001), (intention to treat analysis 68% vs 42%, P`0.001). Among female subjects the corresponding differences were not signi®cant, neither when calculated on completers nor when performed on an intention to treat basis with last observation carried forward (not shown).
The second interaction was between household size and treatment. Among completers living alone, the VLCD-group lost 79.5 AE 19.5 kg and the non VLCDgroup gained 0.8 AE 4.3 kg (ns). The corresponding ®gures for subjects living in two-person households were 717.2 AE 17.0 kg and 75.3 AE 4.6 kg (P 0.08) and for subjects sharing their household with two or more persons, weight losses were 75.4 AE 9.4 kg and 78.5 AE 10.4 kg, respectively (ns). If analysed on an intention to treat basis, there were no signi®cant differences among subjects living alone or among subjects living in larger households (not shown). Among subjects living in two-person households, There was a signi®cant difference in the distribution of male subjects between the various household categories in the VLCD-and non VLCD-group (Table  1b) . If the initial regressions were controlled for gender (the household size 6 treatment model) or household size (the gender 6 treatment model), both interactions still remained signi®cant (not shown).
Drop outs and predictors of attrition
Twenty-six subjects did not complete the study. Of these, two women (one from each treatment group) and one man (the VLCD-group) were not included in the further analyses, since they terminated the study due to reasons unrelated to the treatments per se; two pregnancies and one death from gastrointestinal cancer. Thirteen (22%) subjects dropped out from the VLCD-group and 10 (18%) from the non VLCD-group (ns). In total, six (15%) men and 17 (23%) women dropped out (ns).
If drop outs were strati®ed by sex and treatment the following ®gures were obtained: ®ve VLCD-men (23%) and one non VLCD-men (6%), (P`0.001), eight VLCD-women (22%), nine non VLCD-women (24%) (ns). The mean time until drop-out, was 53 weeks (8±90 weeks) and the average weight loss at the time of attrition was 78.1 AE 8.1 kg. Twenty subjects were willing to state their reason for interrupting the study preterm. Of these, six subjects felt that the treatment was inappropriate or that they needed more support, nine patients did not feel motivated enough, three could not continue due to concurrent disease, either personal or in a close relative. Finally, two subjects dropped out for administrative reasons, for example, living too far away from the hospital. The hunger-score was signi®cantly higher among the drop outs, 8.0 AE 3.4 compared to 6.5 AE 3.0 among the subjects that completed the study, (P 0.05). No other signi®cant differences in baseline variables (Tables 1a, 1b) were observed.
Discussion
VLCDs are well known to produce rapid and profound weight loss in short term studies. 1, 3 In a majority of trials with longer treatment and follow up-periods, VLCD-strategies have not been superior to programs combining hypocaloric diets and behaviour modi®ca-tion. 5, 13, 14 One exception is a study by Miura et al, 15 showing a greater weight loss at two years follow-up in a VLCD-group, than in a group treated with behaviour modi®cation and hypocaloric diet. In the present randomised study, we found no signi®cant bene®t of 12 initial VLCD weeks included in a dietary and behavioural support program, compared to the same supportive strategy alone after two years of active treatment.
Since obesity is a chronic disorder, the need to achieve long term maintenance of weight loss has been stressed. 16 Weight losses of 5±10% have welldocumented bene®cial effects on established cardiovascular risk factors, 17, 18 and have been referred to as a realistic goal for treatment of obese patients. 19, 20 It must be noted that the average weight losses maintained in both treatment groups, at two years, were highly signi®cant and in the range of 5±10% of initial body weight. The present results are also encouraging when compared to the two-year weight losses in the SOS intervention study. Among the ®rst 642 patients that have received conventional treatment in primary health care (subjects participating in the present trial were not included in these results) two-year weight loss was 70.2 AE 8.6 kg, (David Sjo Èstro Èm, unpublished data). This suggests that the structured and continuous dietary and behavioural support, with or without VLCD, offered in the present trial was far superior to the routine care offered to the obese by the general practitioners. The duration of the dietary and behavioural intervention was two years, covering the weight loss as well as the weight maintenance periods. This underscores the fact that it is not suf®cient to just introduce behavioural concepts, obese subjects need constant and continued support. 21, 22 Data on reliable predictors of weight loss, adherence or attrition are scarce and inconsistent. 11, 23 In view of the epidemic increase in obesity prevalence, 24±26 it is important to identify and develop treatment strategies that are effective in achieving long term maintenance of weight loss, and also to identify individuals most likely to respond to a given treatment. 6, 7 In the present trial, analyses of interac- Male subjects in the VLCD-group maintained a signi®cantly greater weight loss than males treated with a support program only. Also, signi®cantly more VLCD-treated male patients maintained weight losses of more than ®ve or ten percent of initial body weight. If analysed on an intention to treat basis, the differences in mean weight losses were somewhat blunted, but there was still a highly signi®cant difference in success rate, de®ned as two-year maintenance of weight loss of b 5%. There are data from other trials pointing at gender related differences in treatment outcome, albeit dif®cult to compare with the present data since the treatment strategies used were different from those in this study. In a one-year study on obese diabetics randomised either to a low calorie diet or to repeated VLCD-periods, Wing et al 27 found that women in the VLCD-group lost signi®cantly more weight than in the low-calorie-diet-group while men had comparable weight losses irrespective of treatment strategy. Thus our results, although not strictly comparable to Wing et al, 27 suggest the opposite, that men bene®t more from VLCD than women, in the longer term.
Additionally, we observed an interaction between household size and treatment but the absolute weight loss differences between subjects living alone or in larger households were not statistically signi®cant between the treatment groups. However, for subjects living in two-person households the VLCD-strategy tended to reduce weight better than the supportive strategy.
The only baseline variable that differed signi®-cantly between the drop-outs and the subjects that completed the study was hunger, drop-outs having signi®cantly higher hunger-scores. This is in accordance with Laporte and Stunkard 28 who reported that the pretreatment hunger-score predicts attrition and dietary nonadherence to a 10 week VLCD-behaviour modi®cation program. There was also a difference in attrition rate between male subjects in the two treatment groups with less men dropping out from the non VLCD-group.
However, the absolute number of drop-outs was small and subdividing even further makes data dif®-cult to interpret.
One limitation of the present analyses is that the trial was designed to test for a main effect of VLCD-treatment. Subjects were thus randomised directly to the two treatment groups. Future studies should be designed speci®cally to investigate the possibility of a differential effect by gender and/or household size.
In conclusion, the identi®cation in the present trial of male subjects as a subgroup that seems to bene®t especially from VLCD-programs and the recognition of baseline predictors of attrition provide further support for the need to individualise obesity treatment. It seems unlikely that any single treatment strategy would work for all obese, but the present study indicates that initial VLCD combined with a support program could be superior to a support program alone in severely obese men.
